- Report
- August 2023
- 168 Pages
Global
From €2858EUR$2,999USD£2,452GBP
- Book
- March 2015
- 256 Pages
- Book
- September 2021
- 576 Pages
- Book
- April 2021
- 6032 Pages
€4021EUR$4,367USD£3,333GBP
- Book
- August 2020
- 432 Pages
- Book
- January 2019
- 504 Pages
- Book
- April 2018
- 472 Pages
- Book
- March 2012
- 544 Pages
- Book
- April 2010
- 308 Pages
- Book
- July 2023
- 512 Pages
- Book
- July 2023
- 512 Pages
- Book
- October 2021
- 352 Pages
High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more